Akebia Therapeutic’s Vafseo® (vadadustat) Granted Additional Patent
New patent with term until 2043 further strengthens patent portfolio WALTHAM, Mass., Nov. 17, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc.
Tagged nasdaq akbaClear
New patent with term until 2043 further strengthens patent portfolio WALTHAM, Mass., Nov. 17, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc.